IGF2BP3 and acute myeloid leukemia: We then confirmed the overexpression of IGF2BP3 in clinical bone marrow samples of patients with AML compared with those of patients with iron deficiency anemia (IDA), and higher IGF2BP3 expression was indeed correlated with the proliferation and apoptosis of leukemic cells.